How to Develop a Winning Patent Portfolio
Speakers: John Storella, Intellectual Property Law For Innovators In Biotechnology
Shirley Recipon, Life Science and Intellectual Property Professional
Date/Time: Friday, April 22, 2016, 11:30 AM - 1:30 PM
Networking lunch: 11:30 AM
Seminar: 12:00: PM
Networking & Questions: 1:00 PM
Place: Molecular Medicine Research Institute
428 Oakmead Pkwy
Sunnyvale, CA 94085
Pricing: Free, but pre-registration is required
John Storella advises early stage biotechnology companies about developing and executing intellectual property strategies. In a career spanning more than 25 years, John has worked at Fish & Neave (now Ropes & Gray), Townsend and Townsend (now Townsend Kilpatrick), Ciphergen Biosystems and Wilson Sonsini. He currently practices from his own offices in Berkeley. His clients have included Biogen, Eli Lilly, Regeneron, Affymetrix, University of California, Geron, Counsyl, Pathwork Diagnostics, Cellerant Therapeutics, IntegenX, Ajinomoto Althea and Guardant Health.
Shirley Recipon applies her over 15 years experience as a Patent Agent in delivering US and foreign patent preparation and prosecution, strategic patent counseling and efficient IP portfolio management. She enjoys seamlessly merging her scientific knowledge, including research at Johns Hopkins and the NIH, to protect and advance a company’s IP position. Her experience includes supporting innovators and business goals and objectives at Incyte, Applied Biosystems, Life Technologies and DuPont
Abstract:Building a patent portfolio is much more than filing patent applications on your inventions. At its best, a patent strategy coordinates technology development with corporate strategy, market opportunity and competitor analysis. A strong patent portfolio gives a company a competitive advantage by creating a zone of exclusion for the valuable features of your product. Patents also protect your freedom to operate by providing defensive and offensive assets against those who would assert their patents against you. A well conceived patent strategy makes your company attractive to investors. They also can be monetized through licensing opportunities.